These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14652793)

  • 61. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.
    Smith KJ; McDonald WI
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1649-73. PubMed ID: 10603618
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Axonal degeneration and progressive neurologic disability in multiple sclerosis.
    Bjartmar C; Trapp BD
    Neurotox Res; 2003; 5(1-2):157-64. PubMed ID: 12832230
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.
    Friese MA; Schattling B; Fugger L
    Nat Rev Neurol; 2014 Apr; 10(4):225-38. PubMed ID: 24638138
    [TBL] [Abstract][Full Text] [Related]  

  • 64. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - Yes.
    Garber JY; Barnett MH
    Mult Scler; 2018 Sep; 24(10):1272-1274. PubMed ID: 29656673
    [No Abstract]   [Full Text] [Related]  

  • 65. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - Commentary.
    Al Sultan AS; Stys PK
    Mult Scler; 2018 Sep; 24(10):1276-1277. PubMed ID: 29656697
    [No Abstract]   [Full Text] [Related]  

  • 66. We should focus more on finding therapeutic targets for the non-inflammatory damage in MS - No.
    't Hart BA; Weissert R
    Mult Scler; 2018 Sep; 24(10):1274-1276. PubMed ID: 29656691
    [No Abstract]   [Full Text] [Related]  

  • 67. Multiple sclerosis: a two-stage disease.
    Steinman L
    Nat Immunol; 2001 Sep; 2(9):762-4. PubMed ID: 11526378
    [No Abstract]   [Full Text] [Related]  

  • 68. Multiple sclerosis: Motor dysfunction.
    Younger DS
    Handb Clin Neurol; 2023; 196():119-147. PubMed ID: 37620066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Editorial comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
    Korczyn AD
    J Neural Transm (Vienna); 2013 Oct; 120(10):1457. PubMed ID: 24057506
    [No Abstract]   [Full Text] [Related]  

  • 70. Chemotactic signaling and beyond: link between interleukin-16 and axonal degeneration in multiple sclerosis.
    Skundric DS
    Neural Regen Res; 2015 Nov; 10(11):1761-3. PubMed ID: 26807108
    [No Abstract]   [Full Text] [Related]  

  • 71. Mechanisms of neuronal damage in multiple sclerosis and its animal models: role of calcium pumps and exchangers.
    Kurnellas MP; Donahue KC; Elkabes S
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):923-6. PubMed ID: 17956247
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improving MS patient care.
    Rieckmann P
    J Neurol; 2004 Sep; 251 Suppl 5():v69-v73. PubMed ID: 15549359
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Neuroprotection in multiple sclerosis: a therapeutic challenge for the next decade.
    Van der Walt A; Butzkueven H; Kolbe S; Marriott M; Alexandrou E; Gresle M; Egan G; Kilpatrick T
    Pharmacol Ther; 2010 Apr; 126(1):82-93. PubMed ID: 20122960
    [TBL] [Abstract][Full Text] [Related]  

  • 75. From inflammation to degeneration: the lessons of clinical trials.
    Comi G
    Neurol Sci; 2003 Dec; 24 Suppl 5():S295-7. PubMed ID: 14652793
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inflammation and degeneration in multiple sclerosis.
    Brück W; Stadelmann C
    Neurol Sci; 2003 Dec; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protecting axons in multiple sclerosis.
    Wilkins A; Scolding N
    Mult Scler; 2008 Sep; 14(8):1013-25. PubMed ID: 18632772
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.